0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessThe safety and activity of the combination of bevacizumab with paclitaxel given either weekly or 3-weekly in patients with MBC is confirmed.
George Fountzilas, Helen P. Kourea, Mattheos Bobos, Despina Televantou, Vassiliki Kotoula, Christos Papadimitriou, Konstantinos Papazisis, Eleni Timotheadou, Ioannis Efstratiou, Αngelos Koutras, George Pentheroudakis, Christos Christodoulou, Gerasimos Aravantinos, Dimosthenis Miliaras, Kalliopi Petraki, Christos N. Papandreou, Pavlos Papakostas, Dimitrios Bafaloukos, Dimitra Repana, Evangelia Razis, Dimitrios Pectasides, Meletios A Dimopoulos (2011). Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation.. , 31(9)
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2011
Authors
22
Datasets
0
Total Files
0
Language
en
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
